ArticleInternational journal of clinical and experimental pathology2018

The loss of CD44 and HSP70 overexpression is related to aggressive clinicopathologic factors in prostate cancer.

Jin A Baek et al.PubMed ↗Full text ↗

No numbers read from the abstract.